Cargando…
Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials
Findings from previous meta-analyses of randomized clinical trials (RCTs) in premature infants with respiratory distress syndrome (RDS) varied as to whether clinical outcomes differed by type of animal-derived pulmonary surfactant; real-world evidence (RWE) was excluded. We extracted study character...
Autores principales: | Sánchez Luna, Manuel, Bacher, Peter, Unnebrink, Kristina, Martinez-Tristani, Marisol, Ramos Navarro, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375954/ https://www.ncbi.nlm.nih.gov/pubmed/32051542 http://dx.doi.org/10.1038/s41372-020-0603-7 |
Ejemplares similares
-
Less Invasive Surfactant Administration: A Review of Current Evidence of Clinical Outcomes With Beractant
por: Sanchez Luna, Manuel, et al.
Publicado: (2022) -
Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study
por: Ramanathan, R, et al.
Publicado: (2013) -
Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study
por: Jeon, Ga Won, et al.
Publicado: (2015) -
The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
por: Pezzi, Mario, et al.
Publicado: (2020) -
Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies
por: Królak-Olejnik, Barbara, et al.
Publicado: (2020)